HK Stock MarketDetailed Quotes

GANFENGLITHIUM (01772)

Watchlist
  • 83.300
  • -0.650-0.77%
Market Closed Apr 30 16:07 CST
174.65BMarket Cap40.52P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GANFENGLITHIUM (01772) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
143.81%9.2B
21.74%22.8B
5.02%14.62B
-13.30%8.26B
-25.43%3.77B
-42.93%18.73B
-45.78%13.93B
-47.41%9.52B
-46.41%5.06B
-20.69%32.81B
Operating income
143.81%9.2B
21.74%22.8B
5.02%14.62B
-13.30%8.26B
-25.43%3.77B
-42.93%18.73B
-45.78%13.93B
-47.41%9.52B
-46.41%5.06B
-20.69%32.81B
Cost of sales
----
-15.59%-19.19B
----
12.94%-7.37B
----
41.28%-16.6B
----
39.56%-8.46B
----
-34.57%-28.27B
Operating expenses
-96.86%-6.46B
-15.59%-19.19B
-1.37%-12.66B
12.94%-7.37B
30.96%-3.28B
41.28%-16.6B
41.21%-12.48B
39.56%-8.46B
19.60%-4.76B
-34.57%-28.27B
Gross profit
459.35%2.73B
69.74%3.61B
36.69%1.97B
-16.22%890.27M
61.74%488.6M
-53.18%2.13B
-67.61%1.44B
-74.15%1.06B
-91.43%302.1M
-77.69%4.54B
Selling expenses
-47.73%-50.83M
-16.83%-171.56M
-52.14%-156.11M
-24.92%-85.44M
-9.05%-34.41M
-31.59%-146.85M
-34.74%-102.61M
-38.20%-68.4M
-5.46%-31.55M
4.91%-111.6M
Administrative expenses
6.97%-292.95M
-26.46%-2.4B
-5.03%-873.1M
0.71%-1.07B
-3.30%-314.9M
18.74%-1.9B
-26.92%-831.26M
-1.61%-1.08B
-102.27%-304.85M
-16.78%-2.34B
Research and development expenses
-88.57%-358.94M
----
-6.43%-729.02M
----
12.22%-190.35M
----
27.26%-684.98M
----
44.67%-216.84M
----
Profit from asset sales
-1,016.50%-81.4K
----
773.06%233.12K
----
70.44%-7.29K
----
-102.50%-34.64K
----
-81.59%-24.67K
----
Revaluation surplus
196.66%217.05M
----
124.93%142.22M
----
16.49%-224.53M
----
-187.70%-570.47M
----
-274.78%-268.86M
----
-Changes in the fair value of other assets
196.66%217.05M
----
124.93%142.22M
----
16.49%-224.53M
----
-187.70%-570.47M
----
-274.78%-268.86M
----
Impairment and provision
56.65%-27.71M
----
18.48%-249.79M
----
34.52%-63.92M
----
69.67%-306.43M
----
91.88%-97.62M
----
-Other impairment is provision
56.65%-27.71M
----
18.48%-249.79M
----
34.52%-63.92M
----
69.67%-306.43M
----
91.88%-97.62M
----
Special items of operating profit
292.66%392.29M
222.78%1.7B
-8.41%652.88M
135.74%272.86M
-71.10%99.91M
-231.66%-1.39B
-83.45%712.82M
-156.31%-763.44M
-42.92%345.73M
2.80%1.05B
Operating profit
1,045.42%2.51B
310.24%2.74B
238.89%569.99M
100.63%5.35M
8.66%-265.19M
-141.41%-1.3B
-106.15%-410.39M
-119.50%-849.13M
-111.65%-290.34M
-83.66%3.15B
Financing income
14.26%78.75M
----
-5.04%219.94M
----
-18.71%68.92M
----
-11.68%231.62M
----
27.46%84.78M
----
Financing cost
-1.32%-308.98M
-35.17%-1.47B
-36.69%-1.05B
-38.89%-703.88M
-29.36%-304.94M
-39.07%-1.09B
-35.57%-768.53M
-47.93%-506.78M
-39.43%-235.73M
-92.55%-784.31M
Share of profits of associates
----
-48.15%38.52M
----
-109.96%-15.61M
----
-91.96%74.3M
----
-74.74%156.7M
----
-44.83%923.76M
Share of profit from joint venture company
----
-570.45%-117.88M
----
-217.71%-229.45M
----
-98.75%25.06M
----
-87.96%194.94M
----
-10.47%2.01B
Special items of earning before tax
470.43%2.82M
----
873.03%16.01M
----
-2,064.28%-760.07K
----
-104.64%-2.07M
----
83.37%-35.12K
----
Earning before tax
522.80%2.24B
151.77%1.19B
52.99%-441.55M
6.04%-943.6M
-6.17%-530.63M
-143.36%-2.3B
-114.83%-939.26M
-116.07%-1B
-121.23%-499.78M
-76.76%5.29B
Tax
----
122.73%74.79M
----
359.80%157.22M
----
51.85%-329.06M
----
83.98%-60.52M
----
70.52%-683.47M
After-tax profit from continuing operations
486.67%1.92B
148.13%1.26B
59.69%-416.04M
26.15%-786.38M
16.55%-497.09M
-156.92%-2.62B
-117.55%-1.03B
-118.13%-1.06B
-127.53%-595.65M
-77.46%4.61B
Earning after tax
486.67%1.92B
148.13%1.26B
59.69%-416.04M
26.15%-786.38M
16.55%-497.09M
-156.92%-2.62B
-117.55%-1.03B
-118.13%-1.06B
-127.53%-595.65M
-77.46%4.61B
Minority profit
160.04%84.81M
37.00%-350.43M
-12.73%-441.56M
18.15%-250.17M
9.88%-141.26M
-49.71%-556.25M
-200.50%-391.7M
-8,806.21%-305.66M
32.62%-156.75M
-765.08%-371.56M
Profit attributable to shareholders
616.34%1.84B
178.01%1.61B
103.99%25.52M
29.37%-536.21M
18.93%-355.83M
-141.52%-2.07B
-110.66%-640.39M
-112.92%-759.14M
-118.31%-438.9M
-75.70%4.98B
Basic earnings per share
588.89%0.88
177.67%0.8
103.13%0.01
28.95%-0.27
18.18%-0.18
-141.70%-1.03
-110.74%-0.32
-113.01%-0.38
-118.49%-0.22
-75.74%2.47
Diluted earnings per share
588.89%0.88
177.67%0.8
103.13%0.01
28.95%-0.27
18.18%-0.18
-141.70%-1.03
-110.74%-0.32
-113.01%-0.38
-118.49%-0.22
-75.71%2.47
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
--
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 143.81%9.2B21.74%22.8B5.02%14.62B-13.30%8.26B-25.43%3.77B-42.93%18.73B-45.78%13.93B-47.41%9.52B-46.41%5.06B-20.69%32.81B
Operating income 143.81%9.2B21.74%22.8B5.02%14.62B-13.30%8.26B-25.43%3.77B-42.93%18.73B-45.78%13.93B-47.41%9.52B-46.41%5.06B-20.69%32.81B
Cost of sales -----15.59%-19.19B----12.94%-7.37B----41.28%-16.6B----39.56%-8.46B-----34.57%-28.27B
Operating expenses -96.86%-6.46B-15.59%-19.19B-1.37%-12.66B12.94%-7.37B30.96%-3.28B41.28%-16.6B41.21%-12.48B39.56%-8.46B19.60%-4.76B-34.57%-28.27B
Gross profit 459.35%2.73B69.74%3.61B36.69%1.97B-16.22%890.27M61.74%488.6M-53.18%2.13B-67.61%1.44B-74.15%1.06B-91.43%302.1M-77.69%4.54B
Selling expenses -47.73%-50.83M-16.83%-171.56M-52.14%-156.11M-24.92%-85.44M-9.05%-34.41M-31.59%-146.85M-34.74%-102.61M-38.20%-68.4M-5.46%-31.55M4.91%-111.6M
Administrative expenses 6.97%-292.95M-26.46%-2.4B-5.03%-873.1M0.71%-1.07B-3.30%-314.9M18.74%-1.9B-26.92%-831.26M-1.61%-1.08B-102.27%-304.85M-16.78%-2.34B
Research and development expenses -88.57%-358.94M-----6.43%-729.02M----12.22%-190.35M----27.26%-684.98M----44.67%-216.84M----
Profit from asset sales -1,016.50%-81.4K----773.06%233.12K----70.44%-7.29K-----102.50%-34.64K-----81.59%-24.67K----
Revaluation surplus 196.66%217.05M----124.93%142.22M----16.49%-224.53M-----187.70%-570.47M-----274.78%-268.86M----
-Changes in the fair value of other assets 196.66%217.05M----124.93%142.22M----16.49%-224.53M-----187.70%-570.47M-----274.78%-268.86M----
Impairment and provision 56.65%-27.71M----18.48%-249.79M----34.52%-63.92M----69.67%-306.43M----91.88%-97.62M----
-Other impairment is provision 56.65%-27.71M----18.48%-249.79M----34.52%-63.92M----69.67%-306.43M----91.88%-97.62M----
Special items of operating profit 292.66%392.29M222.78%1.7B-8.41%652.88M135.74%272.86M-71.10%99.91M-231.66%-1.39B-83.45%712.82M-156.31%-763.44M-42.92%345.73M2.80%1.05B
Operating profit 1,045.42%2.51B310.24%2.74B238.89%569.99M100.63%5.35M8.66%-265.19M-141.41%-1.3B-106.15%-410.39M-119.50%-849.13M-111.65%-290.34M-83.66%3.15B
Financing income 14.26%78.75M-----5.04%219.94M-----18.71%68.92M-----11.68%231.62M----27.46%84.78M----
Financing cost -1.32%-308.98M-35.17%-1.47B-36.69%-1.05B-38.89%-703.88M-29.36%-304.94M-39.07%-1.09B-35.57%-768.53M-47.93%-506.78M-39.43%-235.73M-92.55%-784.31M
Share of profits of associates -----48.15%38.52M-----109.96%-15.61M-----91.96%74.3M-----74.74%156.7M-----44.83%923.76M
Share of profit from joint venture company -----570.45%-117.88M-----217.71%-229.45M-----98.75%25.06M-----87.96%194.94M-----10.47%2.01B
Special items of earning before tax 470.43%2.82M----873.03%16.01M-----2,064.28%-760.07K-----104.64%-2.07M----83.37%-35.12K----
Earning before tax 522.80%2.24B151.77%1.19B52.99%-441.55M6.04%-943.6M-6.17%-530.63M-143.36%-2.3B-114.83%-939.26M-116.07%-1B-121.23%-499.78M-76.76%5.29B
Tax ----122.73%74.79M----359.80%157.22M----51.85%-329.06M----83.98%-60.52M----70.52%-683.47M
After-tax profit from continuing operations 486.67%1.92B148.13%1.26B59.69%-416.04M26.15%-786.38M16.55%-497.09M-156.92%-2.62B-117.55%-1.03B-118.13%-1.06B-127.53%-595.65M-77.46%4.61B
Earning after tax 486.67%1.92B148.13%1.26B59.69%-416.04M26.15%-786.38M16.55%-497.09M-156.92%-2.62B-117.55%-1.03B-118.13%-1.06B-127.53%-595.65M-77.46%4.61B
Minority profit 160.04%84.81M37.00%-350.43M-12.73%-441.56M18.15%-250.17M9.88%-141.26M-49.71%-556.25M-200.50%-391.7M-8,806.21%-305.66M32.62%-156.75M-765.08%-371.56M
Profit attributable to shareholders 616.34%1.84B178.01%1.61B103.99%25.52M29.37%-536.21M18.93%-355.83M-141.52%-2.07B-110.66%-640.39M-112.92%-759.14M-118.31%-438.9M-75.70%4.98B
Basic earnings per share 588.89%0.88177.67%0.8103.13%0.0128.95%-0.2718.18%-0.18-141.70%-1.03-110.74%-0.32-113.01%-0.38-118.49%-0.22-75.74%2.47
Diluted earnings per share 588.89%0.88177.67%0.8103.13%0.0128.95%-0.2718.18%-0.18-141.70%-1.03-110.74%-0.32-113.01%-0.38-118.49%-0.22-75.71%2.47
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ----------Unqualified Opinion------Unqualified Opinion
Auditor ----------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -